Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Rajesh Chavan"'
Publikováno v:
Microbial Drug Resistance. 29:18-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::694baa137c122afcedf8613f22703c41
https://doi.org/10.1089/mdr.2022.0119
https://doi.org/10.1089/mdr.2022.0119
Publikováno v:
Journal of Drug Delivery and Therapeutics. 12:26-32
The remarkable increase in resistance to currently available antibiotics to Gram-negative pathogens particularly multidrug resistant (MDR) Pseudomonas aeruginosa and Acinetobacter baumannii, This has resulted in increasing use of older under evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e70fd5630fc7cb4c2836553107638080
https://doi.org/10.22270/jddt.v12i3-s.5356
https://doi.org/10.22270/jddt.v12i3-s.5356
Autor:
Anouk E Muller, Marie Attwood, Sanne Van den berg, Rajesh Chavan, Hariharan Periasamy, Alan Noel, Alasdair MacGowan
Publikováno v:
Journal of Antimicrobial Chemotherapy, 77(12), 3504-3509. Oxford University Press
Background Very limited studies, so far, have been conducted to identify the pharmacodynamic targets of cefepime, a well-established fourth-generation cephalosporin. As a result, conventional targets representing the cephalosporin class are used for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce39fbbbcd003eeb03971a49bd85f7b
https://pure.eur.nl/en/publications/63221e2e-b341-4d47-88a7-e54f03d8fad5
https://pure.eur.nl/en/publications/63221e2e-b341-4d47-88a7-e54f03d8fad5
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5bca5bbacd1f0486f5a94966ca50c50a
https://pubmed.ncbi.nlm.nih.gov/36346323
https://pubmed.ncbi.nlm.nih.gov/36346323
Publikováno v:
Biomedical Chromatography. 36
A precise and accurate liquid chromatography-tandem mass spectrometric (LC-MS/MS) bioanalytical method has been developed and validated for the simultaneous quantification of WCK 4234 and meropenem (MEM) in dog plasma. Protein precipitation using ace
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319b806b55a78f281c33ba3278d8bdd7
https://doi.org/10.1002/bmc.5377
https://doi.org/10.1002/bmc.5377
Autor:
Satish Bhawsar, Shivaji Pawar, Prasad Deshpande, Ravindra Yeole, Rajesh Chavan, Manohar Nandanwar, Sachin Bhagwat, Mahesh Patel
Publikováno v:
Bioorganicmedicinal chemistry letters. 71
Increased resistance to gram positive infections have highlighted the limitations of currently available drug treatments including penicillins, macrolides and glycopeptides. As an alternative to address these challenges; Linezolid, the first antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51436d30ed71e06dcb978ad2a82de960
https://pubmed.ncbi.nlm.nih.gov/35680102
https://pubmed.ncbi.nlm.nih.gov/35680102
Autor:
Ravindra D. Yeole, Rajesh Chavan, Sachin Bhagwat, Nilesh Chavan, Mahesh Patel, V. S. Zope, Kiran R. Patil
Publikováno v:
Xenobiotica. 51:251-261
Nafithromycin is a next generation lactone ketolide antibiotic slated to enter phase III clinical development in India for the treatment of CABP as a shorter 800 mg-OD X3 day therapeutic regimen. N...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42b71f502b57d9f6f1908dde5676f5c2
https://doi.org/10.1080/00498254.2020.1839983
https://doi.org/10.1080/00498254.2020.1839983
Autor:
Rajesh Chavan, Mahesh Patel, Nilesh Chavan, V. S. Zope, Sachin Bhagwat, Javeed Shaikh, Kiran R. Patil, Ravindra D. Yeole
Publikováno v:
Xenobiotica. 50:1149-1157
WCK 771 (INN: levonadifloxacin) is a novel antibacterial agent belonging to benzoquinolizine subclass of fluoroquinolones which is under clinical development as a parenteral formulation and its pro...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e90b5e7bcc0024c1d66223d77b1e46b
https://doi.org/10.1080/00498254.2020.1756007
https://doi.org/10.1080/00498254.2020.1756007
Autor:
Prasad K Deshpande, Ashima Bhatia, Atul Kansagara, Anusuya Patel, Mahesh Patel, Sachin Bhagwat, Jaishid Ahdal, Swapna Shripad Takalkar, Hariharan Periasamy, Satish Bhavsar, Ravindra D. Yeole, Manohar Nandanwar, Rajesh Chavan, Rishi Jain
Publikováno v:
Drug Design, Development and Therapy. 13:4351-4365
Levonadifloxacin and its prodrug alalevonadifloxacin are novel broad-spectrum anti-MRSA agents belonging to the benzoquinolizine subclass of quinolone, formulated for intravenous and oral administration, respectively. Various in vitro and in vivo stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6acf9eef564183c38b0f3c434b16e5d1
https://doi.org/10.2147/dddt.s229882
https://doi.org/10.2147/dddt.s229882
Autor:
Rajesh, Chavan, Vineet, Zope, Nilesh, Chavan, Kiran, Patil, Ravindra, Yeole, Sachin, Bhagwat, Mahesh, Patel
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 51(3)
Nafithromycin is a next generation lactone ketolide antibiotic slated to enter phase III clinical development in India for the treatment of CABP as a shorter 800 mg-OD X3 day therapeutic regimen. Nafithromycin exhibits potent activity against MDR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce353d9eb57d434cc2cc33afed831606
https://pubmed.ncbi.nlm.nih.gov/33078993
https://pubmed.ncbi.nlm.nih.gov/33078993